PREVIOUS QUESTION:

 

NEXT QUESTION:

 

Is a rheumatoid arthritis (RA) vaccine available for treatment?

ANSWER

Rheumavax is an immunotherapy that still needs FDA approval. It's in the clinical trial phase. Doctors hope to find a way for it to work quicker, simpler, and cheaper. It takes a long time to remove, treat, and replace your dendrite cells.

Still, a 2015 study shows promise: The folks who got the shot showed no signs of inflammation or rheumatoid arthritis (RA) flare-ups a month later.

Once they’ve figured out a quicker prep process and how to get costs down, doctors hope they can make similar kinds of therapies for other autoimmune conditions like type 1 diabetes.

SOURCES:

Johns Hopkins Arthritis Center: “Rheumatoid Arthritis.” 

Stem Cell Reports : “Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs.” 

Katalin Mikecz, MD, PhD, professor, department of orthopedic surgery, Rush Medical College, Chicago. 

Biomedical Reports : “TNF Inhibitor therapy for rheumatoid arthritis.”

Vaccine : “An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis.”

Expert Review of Vaccines : “Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis."

Science Translational Medicine : “Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients.”

Annals of the Rheumatic Diseases : “Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis.”

Reviewed by David Zelman on October 03, 2018

SOURCES:

Johns Hopkins Arthritis Center: “Rheumatoid Arthritis.” 

Stem Cell Reports : “Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs.” 

Katalin Mikecz, MD, PhD, professor, department of orthopedic surgery, Rush Medical College, Chicago. 

Biomedical Reports : “TNF Inhibitor therapy for rheumatoid arthritis.”

Vaccine : “An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis.”

Expert Review of Vaccines : “Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis."

Science Translational Medicine : “Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients.”

Annals of the Rheumatic Diseases : “Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis.”

Reviewed by David Zelman on October 03, 2018

NEXT QUESTION:

When does elderly-onset rheumatoid arthritis (RA) begin?

WAS THIS ANSWER HELPFUL

"ALEXA, ASK WEBMD"

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: